Literature DB >> 19141870

Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.

S F C Vaessen1, G M Dallinga-Thie, C J D Ross, L J Splint, L W Castellani, P C N Rensen, M R Hayden, F G Schaap, J A Kuivenhoven.   

Abstract

Apolipoprotein AV (apoAV) overexpression causes a decrease in plasma triglyceride (TG) levels, while deficiency of apoAV causes hypertriglyceridemia in both men and mice. However, contrary to what would be expected, plasma apoAV and TG levels in humans are positively correlated. To address this apparent paradox, we determined plasma apoAV levels in various mouse models with median TG levels ranging from 30 mg/dl in wild-type mice to 2089 mg/dl in glycosylphosphatidylinositol-anchored HDL binding protein 1-deficient mice. The data show that apoAV and TG levels are positively correlated in mice (r = +0.798, P < 0.001). In addition, we show that LPL gene transfer caused a simultaneous decrease in TG and apoAV in LPL-deficient mice. The combined data suggest that apoAV levels follow TG levels due to an intimate link between the apoAV molecule and TG-rich lipoproteins, comprising both secretion and removal of these lipoproteins. Taken together, the data suggest that higher plasma apoAV levels reflect an increased demand for plasma TG hydrolysis under normal physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141870      PMCID: PMC2666174          DOI: 10.1194/jlr.M800551-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

1.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

Authors:  Len A Pennacchio; Michael Olivier; Jaroslav A Hubacek; Ronald M Krauss; Edward M Rubin; Jonathan C Cohen
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

2.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

Authors:  R J Havel; J P Kane; M L Kashyap
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

3.  Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.

Authors:  P H Weinstock; C L Bisgaier; K Aalto-Setälä; H Radner; R Ramakrishnan; S Levak-Frank; A D Essenburg; R Zechner; J L Breslow
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.

Authors:  L A Pennacchio; M Olivier; J A Hubacek; J C Cohen; D R Cox; J C Fruchart; R M Krauss; E M Rubin
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

5.  Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.

Authors:  Colin J D Ross; Jaap Twisk; Janneke M Meulenberg; Guoqing Liu; Karin van den Oever; Ewoud Moraal; Wim T Hermens; Jaap Rip; John J P Kastelein; Jan Albert Kuivenhoven; Michael R Hayden
Journal:  Hum Gene Ther       Date:  2004-09       Impact factor: 5.695

6.  Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.

Authors:  Rebecca Mar; Päivi Pajukanta; Hooman Allayee; Martine Groenendijk; Geesje Dallinga-Thie; Ronald M Krauss; Janet S Sinsheimer; Rita M Cantor; Tjerk W A de Bruin; Aldons J Lusis
Journal:  Circ Res       Date:  2004-03-04       Impact factor: 17.367

7.  Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.

Authors:  Chao-Qiang Lai; Serkalem Demissie; L Adrienne Cupples; Yueping Zhu; Xian Adiconis; Laurence D Parnell; Dolores Corella; Jose M Ordovas
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

8.  ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

Authors:  Frank G Schaap; Patrick C N Rensen; Peter J Voshol; Carlos Vrins; Hendrik N van der Vliet; Robert A F M Chamuleau; Louis M Havekes; Albert K Groen; Ko Willems van Dijk
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

9.  Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.

Authors:  Michael M Weinstein; Liya Yin; Anne P Beigneux; Brandon S J Davies; Peter Gin; Kristine Estrada; Kristan Melford; Joseph R Bishop; Jeffrey D Esko; Geesje M Dallinga-Thie; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

10.  Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.

Authors:  I J Goldberg; C A Scheraldi; L K Yacoub; U Saxena; C L Bisgaier
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

View more
  5 in total

Review 1.  Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.

Authors:  Vineeta Sharma; Robert O Ryan; Trudy M Forte
Journal:  Biochim Biophys Acta       Date:  2011-12-22

2.  Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion.

Authors:  Anna M Blade; Melissa A Fabritius; Li Hou; Richard B Weinberg; Gregory S Shelness
Journal:  J Lipid Res       Date:  2010-11-26       Impact factor: 5.922

3.  Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.

Authors:  Xiao Shu; Lisa Nelbach; Michael M Weinstein; Braydon L Burgess; Jennifer A Beckstead; Stephen G Young; Robert O Ryan; Trudy M Forte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-21       Impact factor: 8.311

4.  Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.

Authors:  Vineeta Sharma; Jennifer A Beckstead; Jens B Simonsen; Lisa Nelbach; Gordon Watson; Trudy M Forte; Robert O Ryan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-17       Impact factor: 8.311

5.  Plasma lipidomic analysis shows a disease progression signature in mdx mice.

Authors:  Roula Tsonaka; Alexandre Seyer; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.